Venture Visionary Partners LLC lessened its stake in Cigna Group (NYSE:CI – Free Report) by 11.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,190 shares of the health services provider’s stock after selling 284 shares during the period. Venture Visionary Partners LLC’s holdings in Cigna Group were worth $721,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently bought and sold shares of CI. Putney Financial Group LLC acquired a new position in Cigna Group in the fourth quarter valued at $36,000. Evermay Wealth Management LLC boosted its stake in shares of Cigna Group by 58.6% during the first quarter. Evermay Wealth Management LLC now owns 111 shares of the health services provider’s stock worth $37,000 after buying an additional 41 shares during the period. Transce3nd LLC acquired a new stake in shares of Cigna Group during the fourth quarter worth about $38,000. Richardson Financial Services Inc. acquired a new stake in shares of Cigna Group during the first quarter worth about $38,000. Finally, Wayfinding Financial LLC acquired a new stake in shares of Cigna Group during the first quarter worth about $40,000. Institutional investors and hedge funds own 86.99% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the stock. Cowen reiterated a “buy” rating on shares of Cigna Group in a research note on Monday, May 5th. Guggenheim reiterated a “buy” rating and set a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Morgan Stanley increased their target price on shares of Cigna Group from $379.00 to $390.00 and gave the stock an “overweight” rating in a research note on Monday, May 5th. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a report on Thursday, August 14th. Finally, Truist Financial increased their price target on shares of Cigna Group from $385.00 to $405.00 and gave the stock a “buy” rating in a report on Monday, May 12th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $374.82.
Cigna Group Stock Performance
Shares of CI opened at $304.49 on Thursday. The company has a market cap of $81.28 billion, a PE ratio of 16.62, a price-to-earnings-growth ratio of 0.88 and a beta of 0.47. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a 50-day moving average price of $301.44 and a 200-day moving average price of $311.25. Cigna Group has a 12-month low of $256.89 and a 12-month high of $370.83.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the company posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is 32.97%.
Insider Activity
In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.70% of the company’s stock.
About Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More
- Five stocks we like better than Cigna Group
- The 3 Best Fintech Stocks to Buy Now
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- The 3 Best Blue-Chip Stocks to Buy Now
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
- What Are the FAANG Stocks and Are They Good Investments?
- Rocket Lab Stock: Breakout Brewing or Time for Patience?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.